<DOC>
	<DOCNO>NCT02790125</DOCNO>
	<brief_summary>The primary purpose study determine single dos BMS-986166 safe well tolerate healthy male subject female subject non-childbearing potential .</brief_summary>
	<brief_title>A Randomized , Double Blind Placebo-Controlled , Single Ascending Dose Study Evaluate Safety , Tolerability , Pharmacokinetics , Pharmacodynamics BMS-986166 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>For information regard BristolMyers Squibb Clinical Trial participation , please visit www.BMSStudyConnect.com Healthy female subject nonchildbearing potential male subject determine medical history , physical examination , vital sign , 12lead electrocardiogram ( ECG ) , clinical laboratory evaluation Ages 18 55 year Female subject must provide documentation acceptable method surgical sterilization meet protocol criterion menopause Any acute chronic medical illness judge clinically significant Investigator and/or Sponsor medical monitor Any acute chronic bacterial , fungal viral infection , include tuberculosis , HIV , hepatitis B hepatitis C , define protocol History heart disease , neurological disease , eye disorder gastrointestinal disorder surgery ( include cholecystectomy ) Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECGs clinical laboratory test Smoking nicotine use , drug alcohol abuse within 6 month start study Other protocol define inclusion/exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>